Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Syddansk Universitet Forside
Hjælp og FAQ
Dansk
English
Forside
Forskere
Forskningsenheder
Publikationer
Aktiviteter
Projekter
Datasæt
Presse/medie
Priser
Undervisning
Impacts
Søg efter ekspertise, navn eller tilknytning
Vis Scopus-profil
Carl Llor
Institut for Sundhedstjenesteforskning
Lektor
,
Forskningsenheden for Almen Praksis (FEA)
https://orcid.org/0000-0001-6644-717X
Telefon
+4565504463
E-mail
cllor
health.sdu
dk
Oversigt
Fingeraftryk
Netværk
Publikationer
(65)
Lignende forskere
(6)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Carl Llor er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Adverse Event
5%
Antibiotic Resistance
37%
Antibiotic Therapy
41%
Antibiotics
77%
Antiinfective Agent
21%
Antimicrobial Agent
6%
Biological Marker
6%
C Reactive Protein
50%
Chronic Obstructive Pulmonary Disease
12%
Clinical Decision Making
6%
Clinician
5%
Cohort Analysis
6%
Cohort Study
6%
Communication Skill
11%
Community Pharmacy
5%
Community-Acquired Pneumonia
6%
Coughing
9%
Diagnostic Accuracy
7%
Disease Exacerbation
6%
Flu Like Syndrome
6%
Fosfomycin
6%
General Medicine
18%
General Practitioner
35%
Infection
16%
Long-Term Care
6%
Lower Respiratory Tract Infection
19%
Lung
6%
Meta-Analysis
19%
Nursing Home
15%
Observational Study
8%
Odds Ratio
11%
Pharyngitis
7%
Point-of-Care Testing
31%
Predictive Factor
6%
Prevalence
5%
Primary Health Care
88%
Randomized Clinical Trial
15%
Randomized Controlled Trial
21%
Rapid Test
9%
Respiratory Tract Infection
64%
Single Drug Dose
6%
Sputum
5%
Systematic Review
25%
Therapeutic Management
6%
Treatment Duration
8%
Urinary Tract Infection
46%
Urine Culture
5%
Urine Sampling
7%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
7%
Amoxicillin
9%
Antibiotic Agent
6%
Antibiotic Therapy
28%
Antibiotics
100%
Antiinfective Agent
20%
Antimicrobial Agent
6%
Antimicrobial Resistance
56%
Biological Marker
6%
Bronchitis
11%
C Reactive Protein
50%
Cholinergic Receptor Blocking Agent
6%
Chronic Obstructive Lung Disease
15%
Clavulanic Acid
6%
Clinical Study
6%
Cohort Study
13%
Community Acquired Infection
10%
Community Acquired Pneumonia
6%
Community Pharmacy
13%
Coughing
16%
Cystitis
10%
Disease Exacerbation
9%
Diseases
8%
Escherichia coli
6%
Flu Like Syndrome
6%
Fosfomycin
9%
Infection
41%
Lower Respiratory Tract Infection
24%
Observational Study
14%
Penicillin
6%
Penicillin V
5%
Pharyngitis
11%
Prevalence
10%
Randomized Clinical Trial
24%
Randomized Controlled Trial
25%
Respiratory Tract Infection
78%
Sore Throat
5%
Urinary Tract Infection
73%
Nursing and Health Professions
Antibiotic Therapy
19%
Antiinfective Agent
13%
Antimicrobial Agent
6%
Antimicrobial Resistance
36%
Antimicrobial Stewardship
15%
Biological Marker
6%
C Reactive Protein
44%
Clinical Audit
30%
Clinical Decision Making
6%
Clinical Effectiveness
6%
Cohort Analysis
6%
Communication Skill
10%
Confidence Interval
20%
Coughing
9%
Cystitis
8%
Deprescribing
6%
Female Patient
6%
Flu Like Syndrome
6%
Fosfomycin
6%
General Practice
12%
General Practitioner
24%
Health Care Personnel
8%
Indwelling Catheter
7%
Infection
14%
Long Term Care
6%
Lower Respiratory Tract Infection
15%
Lung Ultrasound
6%
Meta Analysis
6%
Nursing Home
22%
Obstructive Lung Disease
6%
Odds Ratio
6%
Point of Care Testing
25%
Practice Guideline
8%
Primary Medical Care
75%
Rapid Test
9%
Respiratory Tract Infection
53%
Single Drug Dose
6%
Systematic Review
18%
Treatment Duration
6%
Urinary Tract Infection
49%
Urine Sampling
13%
